Meditest Spółka z Ograniczoną Odpowiedzialnością (KRS 0000608239, NIP 8513193333) is a Polish company, headquartered in Szczecin, Zachodniopomorskie voivodeship. MEDITEST operates in: Specialist medical practice activities (PKD 86.22.Z). Industry: Healthcare. The company has been listed in the National Court Register since March 17, 2016. MEDITEST's most recently reported net revenue was 0 PLN for 2024.
No reported revenue
The company reported no revenue in any available reporting year. This may indicate a non-operating entity.
No arrears identified in the analyzed sources
No arrears or bankruptcy proceedings identified in the analyzed sources.
Business profile - Meditest
Identity
- Name
- Meditest Spółka z Ograniczoną Odpowiedzialnością
- Legal form
- SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
- Founded
- March 17, 2016
- Registry status as of
- June 24, 2026
- Latest entry
- June 24, 2026
- Founding act
- AKT NOTARIALNY Z DNIA 28 STYCZNIA 2016 R., REP. A NR 134/2016, NOTARIUSZ DOROTA PESZKO, KANCELARIA NOTARIALNA W SZCZECIN…
Articles of association history (1)
- AKT NOTARIALNY Z DNIA 28 STYCZNIA 2016 R., REP. A NR 134/2016, NOTARIUSZ DOROTA PESZKO, KANCELARIA NOTARIALNA W SZCZECINIE,
Activities
Main activity
86.22.ZSpecialist medical practice activities
Other activities
Address and contact
- Address
- UL. BRONISŁAWY, 14, D, 71-533, SZCZECIN, POLSKA
- Voivodeship
- ZACHODNIOPOMORSKIE
- District
- SZCZECIN
- Not disclosed in the registry
- Website
- Not disclosed in the registry
- E-delivery address
- AE:PL-36525-11487-WGADI-29
Risk and payment profile - Meditest
Credibility rating
26.1 / 100
Poor credibility
Insolvency risk
Moderate
Elevated threat
Closure risk
40
/ 100
Risk comparison - scale 0 (safe) → 100 (critical)
Organizational stability signals
No instability signals - ownership, management, PKD codes and company name remain relatively stable.
Shareholder changes
0
0/10 yrs
Board changes
0
0/10 yrs
PKD changes
0
0/10 yrs
Name changes
0
0/10 yrs
Data from 10 years of registry activity.
Credibility history
Payment reliability score from 2018–2024
Current: E (26/100)
Trend: stable (-0.8 pts/year)
Bardzo słaba wiarygodność płatnicza – współpraca handlowa wiąże się z wysokim ryzykiem braku zapłaty.
Trade credit limit history
Standard limit from 2018–2024
Current: 0 PLN
Safe: 0 PLN
Difference between risk models
Closure - probability of ceasing operations (operational continuity). Insolvency - probability of formal bankruptcy / restructuring. The models use different data - results can diverge significantly when balance-sheet data is incomplete.
Operational status - Meditest
Founded
March 17, 2016
10 years in operation
Legal form
SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Registry: RejP
Headquarters
SZCZECIN
ZACHODNIOPOMORSKIE
Primary PKD
86.22.Z
Specialist medical practice activities
Share capital
5.0 K PLN
50 shares total
Shareholders
2
shareholders
Board
1 person
Filed years
7 years
2018–2024 · profitable: 0/7
Registry entries
24
latest: June 24, 2026
Risk signals
Revenue
0 PLN
2024
Net profit
-1.1 K PLN
2024
Assets
100.1 K PLN
2024
Equity
141.39 PLN
2024
Valuation
96.14 PLN
Low confidence
Low confidence
Companies in the same location
Public procurement
Trademarks
Reviews
Rate business credibility - Meditest.
No ratings
Related articles
News
Longevity Center launches Longevity Academy: Poland's first accredited longevity-medicine educational programme for doctors
Warsaw-based Longevity Center sp. z o.o. (KRS 0000796083, ul. Belwederska 9) has launched Longevity Academy - one of the first in the world and the first in Poland accredited longevity-medicine educational programme for doctors. Accreditation by the Polish Medical Chamber; scientific partner: the Buck Institute for Research on Aging in California. The programme is built on 6+ years of clinical practice and 3,000+ patients.
Explainer
Voxel in 2026: a Kraków operator of medical-imaging centres and radiopharmaceuticals, an mWIG40 issuer with a two-member management board
Voxel S.A. (KRS 0000238176), headquartered at ul. Wielicka 265 in Kraków, is a Polish operator of medical-imaging centre networks (MRI, CT, X-ray, ultrasound, mammography) and a radiopharmaceutical producer. The company was founded in 2005, listed on the WSE since 2011. It operates under the Voxel-Diagnostic brand at several dozen locations across Poland. A two-member management board, a five-member supervisory board.
